Xencor reported $7.25M in Interest Income for its fiscal quarter ending in June of 2025.


Interest Income Change Date
AbbVie USD 73M 19M Mar/2025
Alnylam Pharmaceuticals USD 27.49M 1.19M Jun/2025
Arrowhead Research USD 9.62M 2.01M Mar/2025
AstraZeneca 68M 16M Jun/2025
Biogen USD 32.3M 8.4M Jun/2025
Cytokinetics USD 13.7M 1.31M Mar/2025
GlaxoSmithKline 50M 4M Jun/2025
J&J 332M 51M Mar/2025
MacroGenics 1.41M 1.41M Jun/2025
Merck USD 109M 37M Mar/2025
Pfizer USD 156M 13M Jun/2025
Regeneron Pharmaceuticals 174.8M 1.3M Jun/2025
Roche Holding 2M 12M Dec/2020
Xencor USD 7.25M 290K Jun/2025